Medicare Program; Request for Nominations for Members for the Medicare Evidence Development & Coverage Advisory Committee, 78705-78707 [2010-31642]

Download as PDF Federal Register / Vol. 75, No. 241 / Thursday, December 16, 2010 / Notices also be viewed on the Commission’s Web site at https://www.ferc.gov using the ‘‘eLibrary’’ link. Enter the docket number excluding the last three digits in the docket number field to access the document. For assistance, contact FERC Online Support at FERCOnlineSupport@ferc.gov or tollfree at 1–866–208–3676, or for TTY, (202) 502–8659. Kimberly D. Bose, Secretary. [FR Doc. 2010–31565 Filed 12–15–10; 8:45 am] BILLING CODE 6717–01–P FEDERAL ACCOUNTING STANDARDS ADVISORY BOARD Issuance of Exposure Drafts on Implementation Guidance on the Accounting for the Disposal of G– PP&E and Implementation Guidance for Estimating the Historical Cost of G– PP&E Federal Accounting Standards Advisory Board. AGENCY: srobinson on DSKHWCL6B1PROD with NOTICES ACTION: Notice. Board Action: Pursuant to 31 U.S.C. 3511(d), the Federal Advisory Committee Act (Pub. L. 92–463), as amended, and the FASAB Rules of Procedure, as amended in October, 2010, notice is hereby given that the Accounting and Auditing Policy Committee (AAPC) has issued two new Federal Financial Accounting Technical Release exposure drafts entitled Implementation Guidance on the Accounting for the Disposal of G–PP&E and Implementation Guidance for Estimating the Historical Cost of G– PP&E. The Exposure Drafts are available on the FASAB home page https:// www.fasab.gov/exposure.html. Copies can be obtained by contacting FASAB at (202) 512–7350. Respondents are encouraged to comment on any part of the exposure draft. Written comments are requested by February 11, 2011, and should be sent to: Wendy M. Payne, Executive Director, Federal Accounting Standards Advisory Board, 441 G Street, NW., Suite 6814, Mail Stop 6K17V, Washington, DC 20548. FOR FURTHER INFORMATION CONTACT: Wendy Payne, Executive Director, at (202) 512–7350. Authority: Federal Advisory Committee Act, Public Law 92–463. VerDate Mar<15>2010 18:00 Dec 15, 2010 Jkt 223001 Dated: December 10, 2010. Charles Jackson, Federal Register Liaison Officer. [FR Doc. 2010–31538 Filed 12–15–10; 8:45 am] BILLING CODE 1610–02–P FEDERAL RESERVE SYSTEM Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding Company The notificants listed below have applied under the Change in Bank Control Act (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire shares of a bank or bank holding company. The factors that are considered in acting on the notices are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)). The notices are available for immediate inspection at the Federal Reserve Bank indicated. The notices also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing to the Reserve Bank indicated for that notice or to the offices of the Board of Governors. Comments must be received not later than January 3, 2011. A. Federal Reserve Bank of Kansas City (Dennis Denney, Assistant Vice President) 1 Memorial Drive, Kansas City, Missouri 64198–0001: 1. Jeffrey J. Heiman and Jerod J. Heiman, both of Wichita, Kansas; to retain control of Norcon Financial Corp., and thereby indirectly retain control of Conway Bank, National Association, both in Conway Springs, Kansas. Board of Governors of the Federal Reserve System, December 13, 2010. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. 2010–31618 Filed 12–15–10; 8:45 am] BILLING CODE 6210–01–P 78705 owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The application also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than January 10, 2011. A. Federal Reserve Bank of Dallas (E. Ann Worthy, Vice President) 2200 North Pearl Street, Dallas, Texas 75201– 2272: 1. Connemara Bancorp, Inc., Dallas, Texas; to become a bank holding company by acquiring 100 percent of the voting shares of First Amherst Bancshares, Inc., and thereby indirectly acquire voting shares of First National Bank, both in Amherst, Texas. Board of Governors of the Federal Reserve System, December 13, 2010. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. 2010–31617 Filed 12–15–10; 8:45 am] BILLING CODE 6210–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–3241–N] FEDERAL RESERVE SYSTEM Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 Medicare Program; Request for Nominations for Members for the Medicare Evidence Development & Coverage Advisory Committee Centers for Medicare & Medicaid Services, HHS. ACTION: Notice. AGENCY: This notice announces the request for nominations for consideration for membership on the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC). Among other things, the MEDCAC advises the Secretary of the SUMMARY: E:\FR\FM\16DEN1.SGM 16DEN1 78706 Federal Register / Vol. 75, No. 241 / Thursday, December 16, 2010 / Notices srobinson on DSKHWCL6B1PROD with NOTICES Department of Health and Human Services (the Secretary) and the Administrator of the Centers for Medicare & Medicaid Services (CMS), as requested by the Secretary, whether medical items and services are ‘‘reasonable and necessary’’ and therefore eligible for coverage under Title XVIII of the Social Security Act. We are requesting nominations for both voting and nonvoting members to serve on the MEDCAC. Nominees are selected based upon their individual qualifications and not as representatives of professional associations or societies. We have a special interest in ensuring that the interests of both women and men, members of all racial and ethnic groups, and physically challenged individuals are adequately represented on the MEDCAC. Therefore, we encourage nominations of qualified candidates who can represent these interests. The MEDCAC reviews and evaluates medical literature, reviews technology assessments, and examines data and information on the effectiveness and appropriateness of medical items and services that are covered or eligible for coverage under Medicare. DATES: Nominations will be considered if postmarked by Monday, January 31, 2011 and mailed to the address specified in the ADDRESSES section of this notice. ADDRESSES: You may mail nominations for membership to the following address: Centers for Medicare & Medicaid Services, Office of Clinical Standards and Quality, Attention: Maria Ellis, 7500 Security Boulevard, Mail Stop: South Building 3–02–01, Baltimore, MD 21244. FOR FURTHER INFORMATION CONTACT: Maria Ellis, Executive Secretary for the MEDCAC, Centers for Medicare & Medicaid Services, Office of Clinical Standards and Quality, Coverage and Analysis Group, S3–02–01, 7500 Security Boulevard, Baltimore, MD 21244 or contact Ms. Ellis by phone (410–786–0309) or via e-mail at Maria.Ellis@cms.hhs.gov. SUPPLEMENTARY INFORMATION: I. Background On December 14, 1998, we published a notice in the Federal Register (63 FR 68780) announcing establishment of the Medicare Coverage Advisory Committee (MCAC). The Secretary signed the initial charter for the Medicare Coverage Advisory Committee on November 24, 1998. On January 26, 2007 the Secretary published a notice in the Federal Register (72 FR 3853), changing the Committee’s name to the MEDCAC. The VerDate Mar<15>2010 18:00 Dec 15, 2010 Jkt 223001 charter for the committee was recently renewed by the Secretary and will terminate on November 24, 2012, unless renewed again by the Secretary. The MEDCAC is governed by provisions of the Federal Advisory Committee Act, Public Law 92–463, as amended (5 U.S.C. App. 2), which sets forth standards for the formulation and use of advisory committees, and is authorized by section 222 of the Public Health Service Act as amended (42 U.S.C. 217A). The MEDCAC consists of a pool of 100 appointed members including: 6 patient advocates, who are standard voting members, and 6 representatives of industry interests, who are nonvoting members. Members are selected from authorities in clinical medicine of all specialties, administrative medicine, public health, biologic and physical sciences, health care data and information management and analysis, patient advocacy, the economics of health care, medical ethics, and other related professions such as epidemiology and biostatistics, and methodology of trial design. The MEDCAC functions on a committee basis. The committee reviews and evaluates medical literature, reviews technology assessments, and examines data and information on the effectiveness and appropriateness of medical items and services that are covered or eligible for coverage under Medicare. The Committee works from an agenda provided by the Designated Federal Official that lists specific issues, and develops technical advice to assist us in determining reasonable and necessary applications of medical services and technology when we make national coverage decisions for Medicare. The Committee also advises CMS as part of Medicare’s ‘‘coverage with evidence development’’ activities. II. Provisions of the Notice As of June 2011, there will be 19 terms of membership expiring, 2 of which are nonvoting industry representatives and 2 of which are voting patient advocates. Accordingly, we are requesting nominations for both voting and nonvoting members to serve on the MEDCAC. Nominees are selected based upon their individual qualifications and not as representatives of professional associations or societies. We have a special interest in ensuring that women, minority groups, and physically challenged individuals are adequately represented on the MEDCAC. Therefore, we encourage nominations of qualified candidates from these groups. PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 All nominations must be accompanied by curricula vitae. Nomination packages must be sent to Maria Ellis at the address listed in the ADDRESSES section of this notice. Nominees for voting membership must also have expertise and experience in one or more of the following fields: • Clinical medicine of all specialties • Administrative medicine • Public health • Patient advocacy • Biologic and physical sciences • Health care data and information management and analysis • The economics of health care • Medical ethics • Other related professions such as epidemiology and biostatistics, and methodology of clinical trial design We are looking for experts in a number of fields. Our most critical needs are for experts in hematology; genomics; end of life care; Bayesian statistics; clinical epidemiology; clinical trial methodology; knee, hip, and other joint replacement surgery; ophthalmology; psychopharmacology; registries; rheumatology; screening and diagnostic testing analysis; and vascular surgery. We also need experts in biostatistics in clinical settings, cardiovascular epidemiology, dementia, endocrinology, geriatrics, gynecology, minority health, observational research design, stroke epidemiology, and women’s health. The nomination letter must include a statement that the nominee is willing to serve as a member of the MEDCAC and appears to have no conflict of interest that would preclude membership. We are requesting that all curricula vitae include the following: • Date of birth • Place of birth • Social security number • Title and current position • Professional affiliation • Home and business address • Telephone and fax numbers • E-mail address • List of areas of expertise In the nomination letter, we are requesting that the nominee specify whether they are applying for a voting patient advocate position, for another voting position, or as a nonvoting industry representative. Potential candidates will be asked to provide detailed information concerning such matters as financial holdings, consultancies, and research grants or contracts in order to permit evaluation of possible sources of conflict of interest. Members are invited to serve for overlapping 2-year terms. A member E:\FR\FM\16DEN1.SGM 16DEN1 Federal Register / Vol. 75, No. 241 / Thursday, December 16, 2010 / Notices may serve after the expiration of the member’s term until a successor takes office. Any interested person may nominate one or more qualified persons. Self-nominations are also accepted. The current Secretary’s Charter for the MEDCAC is available on the CMS Web site at: https://www.cms.hhs.gov/FACA/ Downloads/medcaccharter.pdf, or you may obtain a copy of the charter by submitting a request to the contact listed in the FOR FURTHER INFORMATION CONTACT section of this notice. Authority: 5 U.S.C. App. 2, section 10(a)(1) and (a)(2). Meeting Dates: We are scheduling the first semi-annual meeting in 2011 for the following dates and times: • Monday, February 28, 2011, 1 p.m. to 5 p.m. eastern standard time (e.s.t.) • Tuesday, March 1, 2011, 8 a.m. to 5 p.m. (e.s.t.) • Wednesday, March 2, 2011, 8 a.m. to 12 Noon (e.s.t.) DATES: Note 1: The times listed in this notice are approximate times; consequently, the meetings may last longer than listed in this notice, but it will not begin before the posted times. (Catalog of Federal Domestic Assistance Program No. 93.773, Medicare—Hospital Insurance; and Program No. 93.774, Medicare—Supplementary Medical Insurance Program.) Note 2: If the Panel’s business concludes by COB on Tuesday (3/1/2011), there will be no meeting on Wednesday (3/2/2011). Dated: December 13, 2010. Barry M. Straube, CMS Chief Medical Officer, Director, Office of Clinical Standards and Quality, Centers for Medicare & Medicaid Services. Deadline for Hardcopy Comments (including the comment in electronic format)/Suggested Agenda Topics— 5 p.m. (e.s.t.), Monday, February 7, 2011. Deadline for Hardcopy Presentations, including the required electronic documents as discussed below— 5 p.m. (e.s.t.), Monday, February 7, 2011. Deadline for Attendance Registration— 5 p.m. (e.s.t.), Wednesday, February 23, 2011. Deadline for Special Accommodations— 5 p.m. (e.s.t.), Wednesday, February 23, 2011. Deadlines [FR Doc. 2010–31642 Filed 12–15–10; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–1573–N] Medicare Program; First Semi-Annual Meeting of the Advisory Panel on Ambulatory Payment Classification Groups—February 28, 2011 Through March 2, 2011 Centers for Medicare & Medicaid Services, Department of Health and Human Services. ACTION: Notice. AGENCY: This notice announces the first semi-annual meeting of the Advisory Panel on Ambulatory Payment Classification (APC) Groups (the Panel) for 2011. The purpose of the Panel is to review the APC groups and their associated weights and to advise the Secretary of the Department of Health and Human Services (DHHS) (the Secretary) and the Administrator of the Centers for Medicare & Medicaid Services (CMS) (the Administrator) concerning the clinical integrity of the APC groups and their associated weights established under the Medicare hospital Outpatient Prospective Payment System (OPPS). We will consider the Panel’s advice as we prepare the proposed rule to update the Medicare hospital Outpatient Prospective Payment System (OPPS) for CY 2012. srobinson on DSKHWCL6B1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 18:00 Dec 15, 2010 Jkt 223001 Submission of Materials to the Designated Federal Officer (DFO) Because of staffing and resource limitations, we cannot accept written comments and presentations by FAX, nor can we print written comments and presentations received electronically for dissemination at the meeting. Only hardcopy comments and presentations can be reproduced for public dissemination. All hardcopy presentations must be accompanied by Form CMS–20017 (revised 01/07). The form is now available through the CMS Forms Web site. The Uniform Resource Locator (URL) for linking to this form is as follows: https://www.cms.hhs.gov/ cmsforms/downloads/cms20017.pdf. Presenters must use the most recent copy of CMS–20017 (updated 01/07) at the above URL. Additionally, presenters must clearly explain the action(s) that they are requesting CMS to take in the appropriate section of the form. They must also clarify their relationship to the organization that they represent in the presentation. (Note: Issues that are vague, or that are outside the scope of the APC Panel’s PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 78707 purpose, will not be considered for presentations and comments. There will be no exceptions to this rule. We appreciate your cooperation on this matter.) We are also requiring electronic versions of the written comments and presentations, in addition to the hardcopies. In summary, presenters and/or commenters must do the following: • Send both electronic and hardcopy versions of their presentations and written comments by the prescribed deadlines. • Send electronic transmissions to the e-mail address below. • Do not send pictures of patients in any of the documents unless their faces have been blocked out. • Do not send documents electronically that have been archived. • Mail (or send by courier) to the DFO all hardcopies, accompanied by Form CMS–20017 (revised 01/07), if they are presenting, as specified in the FOR FURTHER INFORMATION CONTACT section of this notice. • Commenters are not required to send Form CMS–20017 with their written comments. ADDRESSES: The meeting will be held in the Auditorium, CMS Central Office, 7500 Security Boulevard, Baltimore, Maryland 21244–1850. FOR FURTHER INFORMATION CONTACT: Shirl Ackerman-Ross, DFO, CMS, CM, HAPG, DOC, 7500 Security Boulevard, Mail Stop C4–05–17, Baltimore, MD 21244–1850. Phone: (410) 786–4474. E-mail: SAckermanross@cms.hhs.gov. (Note:) We recommend that you advise couriers of the following information: When delivering hardcopies of presentations to CMS, if no one answers at the above phone number, call (410) 786–4532 or (410) 786–9316.) The e-mail address for comments, presentations, and registration requests is CMS APCPanel@cms.hhs.gov. (Note: There is NO underscore in this email address; there is a SPACE between CMS and APCPanel.) News media representatives must contact our Public Affairs Office at (202) 690–6145. Advisory Committees’ Information Lines: The phone numbers for the CMS Federal Advisory Committee Hotline are 1–877–449–5659 (toll free) and (410) 786–9379 (local). Web Sites: Access the CMS Web site at: https://www.cms.hhs.gov/FACA/05_ AdvisoryPanelonAmbulatoryPayment ClassificationGroups.asp#TopOfPage to obtain the following information: (Note: There is an UNDERSCORE after FACA/05(like this_); there is no space.) E:\FR\FM\16DEN1.SGM 16DEN1

Agencies

[Federal Register Volume 75, Number 241 (Thursday, December 16, 2010)]
[Notices]
[Pages 78705-78707]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-31642]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

[CMS-3241-N]


Medicare Program; Request for Nominations for Members for the 
Medicare Evidence Development & Coverage Advisory Committee

AGENCY: Centers for Medicare & Medicaid Services, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces the request for nominations for 
consideration for membership on the Medicare Evidence Development & 
Coverage Advisory Committee (MEDCAC). Among other things, the MEDCAC 
advises the Secretary of the

[[Page 78706]]

Department of Health and Human Services (the Secretary) and the 
Administrator of the Centers for Medicare & Medicaid Services (CMS), as 
requested by the Secretary, whether medical items and services are 
``reasonable and necessary'' and therefore eligible for coverage under 
Title XVIII of the Social Security Act.
    We are requesting nominations for both voting and nonvoting members 
to serve on the MEDCAC. Nominees are selected based upon their 
individual qualifications and not as representatives of professional 
associations or societies. We have a special interest in ensuring that 
the interests of both women and men, members of all racial and ethnic 
groups, and physically challenged individuals are adequately 
represented on the MEDCAC. Therefore, we encourage nominations of 
qualified candidates who can represent these interests.
    The MEDCAC reviews and evaluates medical literature, reviews 
technology assessments, and examines data and information on the 
effectiveness and appropriateness of medical items and services that 
are covered or eligible for coverage under Medicare.

DATES: Nominations will be considered if postmarked by Monday, January 
31, 2011 and mailed to the address specified in the ADDRESSES section 
of this notice.

ADDRESSES: You may mail nominations for membership to the following 
address: Centers for Medicare & Medicaid Services, Office of Clinical 
Standards and Quality, Attention: Maria Ellis, 7500 Security Boulevard, 
Mail Stop: South Building 3-02-01, Baltimore, MD 21244.

FOR FURTHER INFORMATION CONTACT: Maria Ellis, Executive Secretary for 
the MEDCAC, Centers for Medicare & Medicaid Services, Office of 
Clinical Standards and Quality, Coverage and Analysis Group, S3-02-01, 
7500 Security Boulevard, Baltimore, MD 21244 or contact Ms. Ellis by 
phone (410-786-0309) or via e-mail at Maria.Ellis@cms.hhs.gov.

SUPPLEMENTARY INFORMATION: 

I. Background

    On December 14, 1998, we published a notice in the Federal Register 
(63 FR 68780) announcing establishment of the Medicare Coverage 
Advisory Committee (MCAC). The Secretary signed the initial charter for 
the Medicare Coverage Advisory Committee on November 24, 1998. On 
January 26, 2007 the Secretary published a notice in the Federal 
Register (72 FR 3853), changing the Committee's name to the MEDCAC. The 
charter for the committee was recently renewed by the Secretary and 
will terminate on November 24, 2012, unless renewed again by the 
Secretary.
    The MEDCAC is governed by provisions of the Federal Advisory 
Committee Act, Public Law 92-463, as amended (5 U.S.C. App. 2), which 
sets forth standards for the formulation and use of advisory 
committees, and is authorized by section 222 of the Public Health 
Service Act as amended (42 U.S.C. 217A).
    The MEDCAC consists of a pool of 100 appointed members including: 6 
patient advocates, who are standard voting members, and 6 
representatives of industry interests, who are nonvoting members. 
Members are selected from authorities in clinical medicine of all 
specialties, administrative medicine, public health, biologic and 
physical sciences, health care data and information management and 
analysis, patient advocacy, the economics of health care, medical 
ethics, and other related professions such as epidemiology and 
biostatistics, and methodology of trial design.
    The MEDCAC functions on a committee basis. The committee reviews 
and evaluates medical literature, reviews technology assessments, and 
examines data and information on the effectiveness and appropriateness 
of medical items and services that are covered or eligible for coverage 
under Medicare. The Committee works from an agenda provided by the 
Designated Federal Official that lists specific issues, and develops 
technical advice to assist us in determining reasonable and necessary 
applications of medical services and technology when we make national 
coverage decisions for Medicare. The Committee also advises CMS as part 
of Medicare's ``coverage with evidence development'' activities.

II. Provisions of the Notice

    As of June 2011, there will be 19 terms of membership expiring, 2 
of which are nonvoting industry representatives and 2 of which are 
voting patient advocates.
    Accordingly, we are requesting nominations for both voting and 
nonvoting members to serve on the MEDCAC. Nominees are selected based 
upon their individual qualifications and not as representatives of 
professional associations or societies. We have a special interest in 
ensuring that women, minority groups, and physically challenged 
individuals are adequately represented on the MEDCAC. Therefore, we 
encourage nominations of qualified candidates from these groups.
    All nominations must be accompanied by curricula vitae. Nomination 
packages must be sent to Maria Ellis at the address listed in the 
ADDRESSES section of this notice. Nominees for voting membership must 
also have expertise and experience in one or more of the following 
fields:

     Clinical medicine of all specialties
     Administrative medicine
     Public health
     Patient advocacy
     Biologic and physical sciences
     Health care data and information management and analysis
     The economics of health care
     Medical ethics
     Other related professions such as epidemiology and 
biostatistics, and methodology of clinical trial design
    We are looking for experts in a number of fields. Our most critical 
needs are for experts in hematology; genomics; end of life care; 
Bayesian statistics; clinical epidemiology; clinical trial methodology; 
knee, hip, and other joint replacement surgery; ophthalmology; 
psychopharmacology; registries; rheumatology; screening and diagnostic 
testing analysis; and vascular surgery. We also need experts in 
biostatistics in clinical settings, cardiovascular epidemiology, 
dementia, endocrinology, geriatrics, gynecology, minority health, 
observational research design, stroke epidemiology, and women's health.
    The nomination letter must include a statement that the nominee is 
willing to serve as a member of the MEDCAC and appears to have no 
conflict of interest that would preclude membership. We are requesting 
that all curricula vitae include the following:

 Date of birth
 Place of birth
 Social security number
 Title and current position
 Professional affiliation
 Home and business address
 Telephone and fax numbers
 E-mail address
 List of areas of expertise

In the nomination letter, we are requesting that the nominee specify 
whether they are applying for a voting patient advocate position, for 
another voting position, or as a nonvoting industry representative. 
Potential candidates will be asked to provide detailed information 
concerning such matters as financial holdings, consultancies, and 
research grants or contracts in order to permit evaluation of possible 
sources of conflict of interest.
    Members are invited to serve for overlapping 2-year terms. A member

[[Page 78707]]

may serve after the expiration of the member's term until a successor 
takes office. Any interested person may nominate one or more qualified 
persons. Self-nominations are also accepted.
    The current Secretary's Charter for the MEDCAC is available on the 
CMS Web site at: https://www.cms.hhs.gov/FACA/Downloads/medcaccharter.pdf, or you may obtain a copy of the charter by 
submitting a request to the contact listed in the FOR FURTHER 
INFORMATION CONTACT section of this notice.

    Authority:  5 U.S.C. App. 2, section 10(a)(1) and (a)(2).

(Catalog of Federal Domestic Assistance Program No. 93.773, 
Medicare--Hospital Insurance; and Program No. 93.774, Medicare--
Supplementary Medical Insurance Program.)

    Dated: December 13, 2010.
Barry M. Straube,
CMS Chief Medical Officer, Director, Office of Clinical Standards and 
Quality, Centers for Medicare & Medicaid Services.
[FR Doc. 2010-31642 Filed 12-15-10; 8:45 am]
BILLING CODE 4120-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.